Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model
Cited by 22
Related Papers
Covalent targeted radioligands potentiate radionuclide therapy
|Nature|2024|165
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients
|Hepatology International|2023|60
Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma
|BMC Medicine|2024|43
Development and comparison of three 89Zr-labeled anti-CLDN18.2 antibodies to noninvasively evaluate CLDN18.2 expression in gastric cancer: a preclinical study
|European Journal of Nuclear Medicine and Molecular Imaging|2022|39